Pathologic Tumor Response to Neoadjuvant Chemoradiation Predicts Survival in Esophageal Cancer

被引：0
作者：
Moeller, A. [1 ,2 ]
Qureshi, M. M. [1 ,2 ]
Yan, S. X. [2 ]
Dyer, M. A. [1 ,2 ]
Suzuki, K. [1 ,3 ]
Charlot, M. [1 ,4 ]
Everett, P. [1 ,4 ]
Litle, V. [1 ,3 ]
Truong, M. T. [1 ,2 ]
Mak, K. S. [1 ,2 ]
机构：
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
[2] Boston Med Ctr, Dept Radiat Oncol, Boston, MA USA
[3] Boston Med Ctr, Dept Surg, Boston, MA USA
[4] Boston Med Ctr, Dept Med, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2018.07.531
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SU_9_2082
引用
收藏
页码：E35 / E36
页数：2
相关论文
共 50 条
[31]   Predicting outcomes in esophageal adenocarcinoma following neoadjuvant chemoradiation: Interactions between tumor response and survival [J].
Solomon, Daniel ;
Deeb, Ashley L. ;
Tarabine, Kamal ;
Xie, Yue ;
Mazzola, Emanuele ;
Zhao, Lei ;
Hammer, Mark M. ;
Jaklitsch, Michael T. ;
Swanson, Scott J. ;
Bueno, Raphael ;
Wee, Jon O. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 168 (01) :278-289.e4
[32]   Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer [J].
Hammoud, ZT ;
Kesler, KA ;
Ferguson, MK ;
Battafarrano, RJ ;
Bhogaraju, A ;
Hanna, N ;
Govindan, R ;
Mauer, AA ;
Yu, M ;
Einhorn, LH .
DISEASES OF THE ESOPHAGUS, 2006, 19 (02) :69-72
[33]   Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer [J].
Tiesi, Gregory ;
Park, Wungki ;
Gunder, Meredith ;
Rubio, Gustavo ;
Berger, Michael ;
Ardalan, Bach ;
Livingstone, Alan ;
Franceschi, Dido .
JOURNAL OF SURGICAL RESEARCH, 2017, 216 :65-72
[34]   Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced Survival [J].
Donahue, James M. ;
Nichols, Francis C. ;
Li, Zhuo ;
Schomas, David A. ;
Allen, Mark S. ;
Cassivi, Stephen D. ;
Jatoi, Aminah ;
Miller, Robert C. ;
Wigle, Dennis A. ;
Shen, K. Robert ;
Deschamps, Claude .
ANNALS OF THORACIC SURGERY, 2009, 87 (02) :392-399
[35]   FDG PET in predicting pathologic response and survival after preoperative chemoradiation therapy in esophageal cancer [J].
Lee, Pei-Ing ;
You, Dong-Ling ;
Liu, Chia-Chuan ;
Shih, Chih-Hsun ;
Lee, Ming-Yuan ;
Huang, Yu-Yi .
JOURNAL OF NUCLEAR MEDICINE, 2011, 52
[36]   Pathologic Response after Neoadjuvant Therapy is the Major Determinant of Survival in Patients with Esophageal Cancer [J].
Meredith, Kenneth L. ;
Weber, Jill M. ;
Turaga, Kiran K. ;
Siegel, Erin M. ;
McLoughlin, Jim ;
Hoffe, Sarah ;
Marcovalerio, Melis ;
Shah, Nilay ;
Kelley, Scott ;
Karl, Richard .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (04) :1159-1167
[37]   Long-Term Survival Based on Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer [J].
Tiesi, Gregory ;
Stuart, Heather ;
Yakoub, Danny ;
Avisar, Eli ;
Merchant, Nipum ;
Livingstone, Alan S. ;
Franceschi, Dido .
GASTROENTEROLOGY, 2016, 150 (04) :S1175-S1175
[38]   Neoadjuvant chemoradiation for esophageal cancer - surgery improves locoregional control while response evaluation based on PET-CT predicts survival [J].
Hegemann, N. -S. ;
Koepple, R. ;
Walter, F. ;
Boeckle, D. ;
Belka, C. ;
Roeder, F. .
STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 :106-106
[39]   Neoadjuvant chemoradiation for esophageal cancer Surgery improves locoregional control while response based on FDG-PET/CT predicts survival [J].
Hegemann, Nina-Sophie ;
Koepple, Rebecca ;
Walter, Franziska ;
Boeckle, David ;
Fendler, Wolfgang P. ;
Angele, Martin Kurt ;
Boeck, Stefan ;
Belka, Claus ;
Roeder, Falk .
STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (05) :435-443
[40]   Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation [J].
Chirieac, LR ;
Swisher, SG ;
Ajani, JA ;
Komaki, RR ;
Correa, AM ;
Morris, JS ;
Roth, JA ;
Rashid, A ;
Hamilton, SR ;
Wu, TT .
CANCER, 2005, 103 (07) :1347-1355
12345